Embolism

"Embolism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.

Descriptor ID	D004617
MeSH Number(s)	C14.907.355.350
Concept/Terms	Embolism Embolism Embolisms Embolus Embolus

Below are MeSH descriptors whose meaning is more general than "Embolism".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Embolism and Thrombosis [C14.907.355]
Embolism [C14.907.355.350]

Below are MeSH descriptors whose meaning is related to "Embolism".

Below are MeSH descriptors whose meaning is more specific than "Embolism".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Embolism" by people in this website by year, and whether "Embolism" was a major or minor topic of these publications.

Bar chart showing 40 publications over 18 distinct years, with a maximum of 7 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2004	0	1	1
2005	1	0	1
2007	0	1	1
2008	1	0	1
2009	0	1	1
2010	1	3	4
2011	1	1	2
2012	3	0	3
2013	4	3	7
2014	1	0	1
2015	1	2	3
2016	2	2	4
2017	1	0	1
2018	0	1	1
2019	1	2	3
2020	1	1	2
2021	1	2	3

Below are the most recent publications written about "Embolism" by people in Profiles.

Mamas MA, Batson S, Pollock KG, Grundy S, Matthew A, Chapman C, Manuel JA, Farooqui U, Mitchell SA. Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation. Am J Cardiol. 2022 03 01; 166:58-64.

View in: PubMed
Chaudhry UA, Ezekowitz MD, Gracely EJ, George WT, Wolfe CM, Harper G, Harper GR. Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged =80 years With Atrial Fibrillation. Am J Cardiol. 2021 08 01; 152:69-77.

View in: PubMed
Millenaar D, Schumacher H, Brueckmann M, Eikelboom JW, Ezekowitz M, Slawik J, Ewen S, Ukena C, Wallentin L, Connolly S, Yusuf S, B?hm M. Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial). Am J Cardiol. 2021 06 15; 149:27-35.

View in: PubMed
Hijazi Z, Wallentin L, Lindb?ck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Pol T, Yusuf S, Oldgren J, Siegbahn A. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation. J Am Heart Assoc. 2020 12 15; 9(24):e018984.

View in: PubMed
Shoaib A, Ratib K, Mamas M. Reply: Embolic Protection: Should it Be Put in the Dustbin of History or Are There Other Alternatives? JACC Cardiovasc Interv. 2020 03 23; 13(6):784-785.

View in: PubMed
Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. Am Heart J. 2020 01; 219:21-30.

View in: PubMed
Wolf R, Parish LC, Parish JL. The rash from nuisance to life threatening: Part II. Clin Dermatol. 2020 Jan - Feb; 38(1):1-2.

View in: PubMed
Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. JAMA Cardiol. 2019 08 01; 4(8):756-764.

View in: PubMed
Ezekowitz MD, Pollack CV, Halperin JL, England RD, VanPelt Nguyen S, Spahr J, Sudworth M, Cater NB, Breazna A, Oldgren J, Kirchhof P. Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial. Eur Heart J. 2018 08 21; 39(32):2959-2971.

View in: PubMed
Li CH, Ma SKT, Chang RS. Cardioembolic stroke and cardiomyopathy: Rhythm is the key. J Neurol Sci. 2017 09 15; 380:172-173.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement